squamous cell carcinoma of the oral cavity
Showing 1 - 22 of 22
Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- +3 more
- Eliminating RT to the elective neck
- RT standard of care
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Circulating tumor DNA detection
-
Rouen, France
- +1 more
Jun 29, 2023
HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in
Not yet recruiting
- HPV-Related Squamous Cell Carcinoma
- +4 more
- Cisplatin
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B)
Active, not recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jan 18, 2023
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Larynx Trial (Hypofractionated
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Hypofractionated Postoperative Radiotherapy
- (no location specified)
Sep 12, 2022
Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate Trial in Worldwide (biological, drug,
Completed
- Squamous Cell Carcinoma of the Oral Cavity
- Squamous Cell Carcinoma of the Soft Palate
- LI
- +6 more
-
Springfield, Illinois
- +101 more
Aug 17, 2022
Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)
Withdrawn
- Head and Neck Squamous Cell Carcinoma
- +4 more
- (no location specified)
Aug 1, 2022
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B KAC)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B KAC
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 6, 2022
Squamous Cell Carcinoma of the Oral Cavity Trial in Edmonton (Resource® Support Plus)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Resource® Support Plus
-
Edmonton, Alberta, CanadaCross Cancer Institute
May 13, 2022
Squamous Cell Carcinoma of the Head and Neck, Oral Cancer, Squamous Cell Carcinoma of the Oral Cavity Trial in Rotterdam
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +2 more
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Mar 23, 2022
Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (GL-0817, Hiltonol, Sargramostim)
Completed
- Squamous Cell Carcinoma of the Oral Cavity
- GL-0817
- +4 more
-
Baltimore, Maryland
- +32 more
Mar 4, 2022
Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Squamous Cell Carcinoma of the Oral Cavity Trial in
Completed
- Squamous Cell Carcinoma, Head And Neck
- +2 more
- Sitravatinib
- Nivolumab
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Mar 30, 2021
Squamous Cell Carcinoma of the Oral Cavity Trial in Bebington (Nivolumab, Surgery, Radiotherapy, Nivolumab, Surgery,
Active, not recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Nivolumab, Surgery, Radiotherapy
- Nivolumab, Surgery, Chemoradiotherapy
-
Bebington, United KingdomClatterbridge Cancer Centre NHS Foundation Trust
Jan 4, 2021
Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (biological, drug, dietary supplement)
Unknown status
- Squamous Cell Carcinoma of the Oral Cavity
- IRX-2
- +4 more
-
Tucson, Arizona
- +21 more
Aug 11, 2020
Squamous Cell Carcinoma of the Oral Cavity Trial in Taipei (ß-glucan)
Unknown status
- Squamous Cell Carcinoma of the Oral Cavity
- β-glucan
-
Taipei, TaiwanNational Taiwan University Hospital
May 10, 2020
Squamous Cell Carcinoma of the Oral Cavity Trial (surgical excision)
Unknown status
- Squamous Cell Carcinoma of the Oral Cavity
- surgical excision
- (no location specified)
Nov 30, 2017
Squamous Cell Carcinoma of the Oral Cavity Trial in Berlin, L'Hospitalet de Llobregat Barcelona, Madrid (drug, procedure,
Terminated
- Squamous Cell Carcinoma of the Oral Cavity
- IPH2201
- +2 more
-
Berlin, Germany
- +2 more
Jan 2, 2017
Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx Trial in United States (GC4419)
Completed
- Squamous Cell Carcinoma of the Oral Cavity
- Squamous Cell Carcinoma of the Oropharynx
-
Lakeland, Florida
- +9 more
Sep 21, 2016
Oropharynx Cancer, Squamous Cell Carcinoma of the Oral Cavity Trial in Germany (Taxotere, Cisplatin, 5-Fluorouracil (5-FU))
Completed
- Oropharynx Cancer
- Squamous Cell Carcinoma of the Oral Cavity
- Taxotere, Cisplatin, 5-Fluorouracil (5-FU)
-
Bielefeld, Germany
- +3 more
May 17, 2016
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Completed
- Squamous Cell Carcinoma of the Oral Cavity
- +3 more
-
New York, New YorkMount Sinai School of Medicine
Jun 20, 2012
F-18-FDG-PET and Optical Imaging in Evaluation of
Terminated
- Squamous Cell Carcinoma of the Oral Cavity
- +2 more
- endoscopic examination
- FDG-PET
-
Ghent, BelgiumUniversity Hospital Ghent
May 25, 2011